acta diurna · run record
2026-10-28-medtech
28 October 2026 ·published
| # | stage | model | verdict | retries | notes | cost |
|---|---|---|---|---|---|---|
| 01 | nuncio | deepseek/deepseek-v4-flash | — | — | rss:FierceBiotech failed (Cannot convert object to primitive value) [optional] | rss:Fierce Pharma failed (Cannot convert object to primitive value) [optional] | 1 gathered stories already covered by the Specola — excluded: "STAT+: Roche gets a lung cancer win with its KRAS drug divarasib" | $0.0007 |
| 02 | bulletins | anthropic/claude-sonnet-5 | — | — | "FDA details quicker approval pathway for personalized gene therapies": pass (1 redispatch) | "Nonprofit resurrects shelved gene therapy after startup shuts down": pass (0 redispatch) | "Epic's dominance chokes innovation in health technology, investigation finds": pass (1 redispatch) | "Artiva shuts down after two deaths in autoimmune cell therapy trial": pass (0 redispatch) | $0.0580 |
| 03 | dispatch | anthropic/claude-sonnet-5 | pass | — | $0.0664 | |
| 04 | rounds | anthropic/claude-sonnet-5 | pass | — | $0.0326 | |
| 05 | illuminate-rounds | — | — | — | skipped: no FAL_KEY — "The Chokehold Is Not a Chokepoint" publishes without a plate | $0.0000 |
| the day's wage | $0.1577 | |||||